Published in Medical Imaging Week, November 25th, 2006
This trend article about Stanford University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New investigation results, "Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays," are detailed in a study published in Biochemistry. "In vivo bioluminescence imaging has become a cornerstone technology for preclinical molecular imaging. This imaging method is based on light-emitting enzymes, luciferases, which require specific substrates for light production," researchers in the United States report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Week